Organon Pharma Indonesia Tbk. vs Victoria Investama Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Victoria Investama Tbk. trades at Rp168 (market cap 2.65T, 1.08M 24h volume). The key difference: Victoria Investama Tbk. is far larger — about 25.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | VICO | |
|---|---|---|
Market Cap | 104.4B | 2.65T |
Volume | — | 1.08M |
Lot | — | 10.78K |
Turnover | — | 184.98M |
Average Price | — | 171.57 |
Value | — | 184.98M |
Indicative Equilibrium Price | — | 168 |
Indicative Equilibrium Volume | — | 142 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Victoria Investama Tbk (formerly PT Victoria Sekuritas) was establised under its original name of PT Tata Sekuritas Maju on October 26, 1989.
Read more on VICO →